The Medical Management in Patients Exposed to Weapons of Mass Destruction

NCT05026645 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-10-01

No results posted yet for this study

Summary

Observation study measuring medical response in contaminated environment.

Conditions

  • Chemical Injury
  • Chemicals; Intoxication
  • Acute Respiratory Distress Syndrome
  • Distress Respiratory Syndrome
  • Medical Emergencies

Interventions

PROCEDURE

Clinical interventions performed in acute settings (contaminated environment)

Any clinical intervention performed on the patient inflicted by at least one of Chemical, Biological, Radiological, Nuclear, Explosive (CBRNE) weapons in acute settings (from the incident site up to his/her admission to the clean zone of a emergency room or its equivalent (ie.: walking clinic).

PROCEDURE

Protection (clinician and patient)

As interrelated competence of the clinical intervention, any protection procedure and capability applied on the patient inflicted by at least one of Chemical, Biological, Radiological, Nuclear, Explosive (CBRNE) weapons in acute settings (from the incident site up to his/her admission to the clean zone of a emergency room or its equivalent (ie.: walking clinic). Concerning the clinician, the protection implied for his/her own safety and for the patient to whom she/he was in closed/contact with.

PROCEDURE

Decontamination (clinician and patient)

As interrelated competence of the clinical intervention and protection, any decontamination procedure and capability applied on the patient inflicted by at least one of Chemical, Biological, Radiological, Nuclear, Explosive (CBRNE) weapons in acute settings (from the incident site up to his/her admission to the clean zone of a emergency room or its equivalent (ie.: walking clinic). Concerning the clinician, the protection implied for his/her own safety and for the patient to whom she/he was in closed/contact with. This crucial step is usually expected prior the patient's transfer into a clean zone like the emergency room or its equivalent.

Sponsors & Collaborators

  • Quebec Heart and Lung Institute, Quebec City, Canada

    collaborator UNKNOWN
  • Sorbonne University

    collaborator OTHER
  • Medical Intelligence CBRNE inc.; Quebec City, Canada

    collaborator UNKNOWN
  • Department of Intensive Care Medicine, Tokyo, Japan

    collaborator UNKNOWN
  • Centre for Defence and Security Studies, University of Manitoba, Winnipeg, Canada

    collaborator UNKNOWN
  • Biomedical Telematics Laboratory, Quebec Respiratory Health Research Network, Sherbrooke, Canada

    collaborator UNKNOWN
  • Tokyo University

    collaborator OTHER
  • Tokyo Women's Medical University

    collaborator OTHER
  • University of Maryland, College Park

    collaborator OTHER
  • St. Justine's Hospital

    lead OTHER

Principal Investigators

  • Stephane Bourassa · Ste-Justine's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2036-11-01
Completion
2036-12-01

Countries

  • United States
  • Canada
  • Czechia
  • France
  • Japan
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05026645 on ClinicalTrials.gov